Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 19
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03117101 | Study of the AL3810 in the Treatment of Advanced Solid Tumor | ||
| NCT03544905 | Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33 | ||
| NCT06975618 | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM) | ||
| NCT03260179 | Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810 | ||
| NCT04390737 | Evaluate the Safety and Clinical Activity of HH2853 | ||
| NCT06909877 | Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma | ||
| NCT01832298 | Study of Simmitecan Hydrochloride in the Treatment of Advanced Solid Tumor | ||
| NCT03466268 | Study to Evaluate the Safety and Anti-tumor Activity of SCC244 | ||
| NCT04746612 | First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors | ||
| NCT04856371 | Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer | ||
| NCT02870036 | Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors | ||
| NCT03457532 | A Phase I Study of SCC244 in Patients with Advanced MET Alterations Solid Tumors | ||
| NCT04586335 | Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. | ||
| NCT04270591 | Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer | ||
| NCT04198818 | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors | ||
| NCT05043922 | A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma | ||
| NCT05507294 | Single Dose Glumetinib in Healthy Chinese Male Subjects | ||
| NCT04338243 | Glumetinib Combined With Osimertinib in the Treatment of Relapsed and Metastatic Non-small Cell Lung Cancer Patients Who Failed to Receive EGFR Inhibitors | ||
| NCT04254471 | This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients |
